Acquisitions - Schedule of Intangible Assets Acquired (Details) - USD ($) $ in Thousands |
Mar. 09, 2026 |
Jul. 31, 2026 |
Jan. 31, 2026 |
|---|---|---|---|
| Intangible Asset, Indefinite-Lived, Acquired [Line Items] | |||
| Goodwill | $ 492,991 | $ 439,877 | |
| Rise Healthcare Tech, Inc. (Ostro) | |||
| Intangible Asset, Indefinite-Lived, Acquired [Line Items] | |||
| Fair Value | $ 25,500 | ||
| Goodwill | $ 44,423 | ||
| Rise Healthcare Tech, Inc. (Ostro) | Trade names and trademarks | |||
| Intangible Asset, Indefinite-Lived, Acquired [Line Items] | |||
| Useful life | 3 years | ||
| Fair Value | $ 1,300 | ||
| Rise Healthcare Tech, Inc. (Ostro) | Developed technology | |||
| Intangible Asset, Indefinite-Lived, Acquired [Line Items] | |||
| Useful life | 5 years | ||
| Fair Value | $ 14,500 | ||
| Rise Healthcare Tech, Inc. (Ostro) | Customer relationships | |||
| Intangible Asset, Indefinite-Lived, Acquired [Line Items] | |||
| Useful life | 7 years | ||
| Fair Value | $ 9,700 |
| X | ||||||||||
- Definition Weighted-average period of amortization for finite-lived intangible asset acquired in business combination, asset acquisition, and from joint venture formation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in finite-lived intangible asset acquired in business combination, asset acquisition, and from joint venture formation. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|